SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aurobindo Pharma informs about allotment of Shares under ESOP

07 Oct 2014 Evaluate

Aurobindo Pharma has informed that the company has made allotment of 7,700 Equity Shares of Re 1 each of the company at a premium of Rs 186.40 per equity share under ESOP-2006 of the company on October 07, 2014. Consequent to the allotment the paid up share capital of the company has increased from 29,14,57,021 Equity Shares of Re 1 each to 29,14,64,721 Equity Shares of Re 1 each.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1377.90 -7.75 (-0.56%)
20-Apr-2026 09:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.45
Dr. Reddys Lab 1235.10
Cipla 1233.00
Zydus Lifesciences 939.95
Lupin 2330.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×